Delay in cell separation, storage and anticoagulants induced inaccuracies in measuring plasma non-esterified fatty acids

Effects of blood sample collection and preparation methods on concentrations of glucose and nonesterified fatty acids in dairy cattle

Measurement of concentrations of glucose and nonesterified fatty acids (NEFA) in blood is common in nutrition and physiology studies. Proper collection and preparation conditions of the blood have been less well studied in dairy cattle. The objective of this experiment was to determine concentrations of glucose and NEFA in blood prepared with different anticoagulants (heparin vs. EDTA), use of fluoride as a glycolysis inhibitor, time until centrifugation (<30 min to 2.5 h), and plasma versus serum. Blood samples were obtained from 30 lactating cows and 15 milk-fed calves into 5 evacuated test tubes. Three of the tubes contained K3 EDTA and 1 tube contained heparin as anticoagulants to prepare plasma, and the fifth tube was a serum separator tube. One of the EDTA tubes was inverted and divided into 2 tubes containing NaF. One of the tubes with NaF and 1 EDTA tube were centrifuged within 30 min of collection and the others were held on ice for another 2 h before centrifugation. The heparin tube and the serum separator tube were centrifuged within 30 min. Glucose and NEFA were measured in the samples using enzymatic kits. Data were divided into 2 data sets representing normal dairy cow values or elevated values for glucose and NEFA. For glucose concentrations, results indicated that fluoride decreased concentrations, that a 2-h holding time before centrifugation did not affect results, and that serum and EDTA plasma resulted in lower glucose than heparin plasma. For low NEFA concentrations, addition of fluoride to the EDTA tubes resulted in a significant decrease of NEFA concentration. The effect of time sitting before centrifugation was significant for low NEFA samples, but contrary to our expectations, the effect was to decrease NEFA rather than increase it. Heparin as an anticoagulant did not affect NEFA concentrations in the low NEFA samples relative to EDTA. Heparin resulted in lower NEFA than serum in low NEFA samples. Serum and EDTA plasma resulted in similar NEFA concentrations. In the high NEFA samples, experimental power was limited due to the small sample size, but fluoride and time did not affect NEFA concentrations. Heparin tended to result in greater NEFA relative to EDTA. Serum produced greater NEFA values compared with EDTA but did not differ from heparin plasma. While differences among preparation methods were small and of limited biological significance, these results provide guidance for collection and processing of blood samples intended for glucose and NEFA assay.

The Use of Biochemical Measurements to Identify Pre-Slaughter Stress in Pasture Finished Beef Cattle

This study considered the relationship between pre-slaughter stressors and plasma biomarkers in 488 pasture-raised cattle across two experiments. The design aimed to test groups consisting of steer only, heifer only, and mixed sex cattle under direct kill versus rested (14 days in abattoir holding paddocks) protocols. In Experiment One, cattle were sourced from four farms, and transported by trucks and ships on the same day. In Experiment Two, cattle were sourced from four farms where a comparison was made between marketing via two commercial saleyards or direct farm gate consignment to abattoir. Blood samples were collected at exsanguination for subsequent analyses and relation to meat quality attributes. Muscle damage, as indicated by creatine kinase, is the biomarker most correlated to ultimate pH and muscle glycogen concentrations. A two-week rest period is effective for lowering this enzyme and improving muscle glycogen concentration. Although the cattle was subjected to a range of stress inducing treatments, we found that plasma biomarkers alone appeared insufficient for use as diagnostic stress indicators.

Comparative Serum Fatty Acid Profiles of Captive and Free-Ranging Cheetahs (Acinonyx jubatus) in Namibia

Cheetahs (Acinonyx jubatus) are highly specialised large felids, currently listed as vulnerable on the IUCN red data list. In captivity, they are known to suffer from a range of chronic non-infectious diseases. Although low heterozygosity and the stress of captivity have been suggested as possible causal factors, recent studies have started to focus on the contribution of potential dietary factors in the pathogenesis of these diseases. Fatty acids are an important component of the diet, not only providing a source of metabolisable energy, but serving other important functions in hormone production, cellular signalling as well as providing structural components in biological membranes. To develop a better understanding of lipid metabolism in cheetahs, we compared the total serum fatty acid profiles of 35 captive cheetahs to those of 43 free-ranging individuals in Namibia using gas chromatography-mass spectrometry. The unsaturated fatty acid concentrations differed most remarkably between the groups, with all of the polyunsaturated and monounsaturated fatty acids, except arachidonic acid and hypogeic acid, detected at significantly lower concentrations in the serum of the free-ranging animals. The influence of age and sex on the individual fatty acid concentrations was less notable. This study represents the first evaluation of the serum fatty acids of free-ranging cheetahs, providing critical information on the normal fatty acid profiles of free-living, healthy individuals of this species. The results raise several important questions about the potential impact of dietary fatty acid composition on the health of cheetahs in captivity.

Effect of Anticoagulant and Storage Conditions on Bovine Nonesterified Fatty Acid and β-Hydroxybutyrate Concentrations in Blood

The objective of this study was to determine if nonesterified fatty acid (NEFA) and beta-hydroxybutyrate (BHBA) concentrations were affected by anticoagulants or gel and clot activator tubes (serum separator tubes, SST), storage of samples as whole blood, separated plasma or serum at 24 degrees C or 4 degrees C for 24 to 72 h, or storage as serum at -40 degrees C for 1 mo. Blood was collected from dairy cows into EDTA, heparin, nonanticoagulant tubes, and SST, and analyzed immediately to obtain baseline NEFA and BHBA concentrations. Portions were stored as whole blood or separated plasma or serum at 4 or 24 degrees C and assayed daily for 24 (whole blood) and 72 (separated samples) h. Serum samples were frozen at -40 degrees C and assayed at 24 h or weekly for 1 mo. Baseline NEFA concentrations were unaffected by anticoagulants; however, they were significantly higher in SST compared with nonanticoagulant tubes. Concentrations of NEFA were stable in all samples at 4 degrees C, whereas they sequentially increased from 24 to 48 h at 24 degrees C. Changes were more dramatic in heparinized samples. Serum could be stored frozen for up to 1 mo with minimal changes in NEFA concentrations. Concentrations of BHBA were stable under all conditions evaluated. Our results indicated that blood for NEFA testing should be collected into EDTA or nonanticoagulant tubes (but not SST), separated promptly from cells, and maintained at 4 degrees C until analysis.

Binding of ketoprofen enantiomers in various human albumin preparations

Published data conflict with respect to the enantioselective protein binding parameters of R(-) and S(+) ketoprofen. We studied whether differences in experimental conditions used and/or presence of interfering compounds could provide a possible explanation for these discrepancies. Equilibrium dialysis, supported by ultrafiltration (67 mM Sörensen phosphate buffer pH 7.4, 580 microM HSA, 37 degrees C) allowed the characteristics of the binding sites to be determined according to Scatchard's analysis. (R) and (S)-ketoprofen concentrations were measured by HPLC. The free (R)-ketoprofen/free (S)-ketoprofen (F(R)/F(S)) concentration ratio was calculated. The effect of octanoic acid (OA) found in currently marketed intravenous HSA solutions, and hippuric acid (HA), on F(R)/F(S) concentration ratio was considered. Two classes of binding sites were characterized for both enantiomers. The free (S)-ketoprofen concentrations remained equal to those of the (R)-antipode at low concentrations of racemate (2-35 microg ml(-1)) indicating non-stereoselective albumin binding over the therapeutic range. From 35 microg ml(-1), the free (S)-ketoprofen concentrations were slighty greater than those of its antipode. Both OA and HA induced an increase of the free fraction of the enantiomers by a two-fold to a 15-fold order of magnitude. OA, but not HA, showed a more pronounced effect for the (S)-form leading to a marked decrease in F(R)/F(S) concentration ratio (0.61). Differences in HSA preparations used and/or the presence of interfering compounds may explain the variability in the reported protein binding characteristics of ketoprofen enantiomers.

Slow replenishment of carnitine deficiency after cessation of long-term treatment with pivaloyl-containing antibiotics

Long-term treatment with pivampicillin and pivmecillinam for 6-24 months in five adults and one child reduced the total serum carnitine concentration to 3.7-14 mumol/l (reference value: 25-66 mumol/l). Muscle carnitine was reduced to 0.3-0.7 mumol/g wet weight (reference value: 3-5 mumol/g) in two cases. All patients had muscle symptoms with weakness, asthenia and pains. One showed signs of carnitine depletion in the liver with increased secretion of dicarboxylic acids (C6, C8, C10) in urine and limited ketone body formation during prolonged fasting. Serum carnitine increased slowly after cessation of therapy and reached normal concentrations after 6-12 months. All symptoms caused by carnitine depletion disappeared. This was achieved on a normal diet without carnitine supplementation.

Reduced carnitine and ketogenesis in the pivampicillin treated rat

Pivampicillin (630 mg/kg body wt) given daily by stomach tube induced carnitine deficiency in the rat. The carnitine concentrations after 24 days were significantly reduced to (mean +/- SD) 34 +/- 2, 27 +/- 7, 70 +/- 18, 75 +/- 16 and 49 +/- 4% of controls in plasma, liver, muscle, heart and kidney, respectively, without any further reduction after 36 days. Pivampicillin treatment reduced the carnitine concentrations in the liver of the 48 hr fasted rat to about 1/2 of the controls after 6 days. The concentration of beta-hydroxybutyrate was significantly reduced up to 14 days of treatment, and again increased. There was no significant difference in the free fatty acid concentrations between treated and control rats. Thus, pivampicillin treatment induced carnitine deficiency in the rat, but not as pronounced as seen in humans. This is possibly caused by adjustment of bacterial flora in the gut or altered renal mechanisms. The pivampicillin-treated rat, therefore, is not a useful model for pronounced carnitine deficiency in humans.